UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biased ligands at G-protein-coupled receptors: promise and progress

Trends in pharmacological sciences (Regular ed.), 2014-07, Vol.35 (7), p.308-316

2014

Volltextzugriff (PDF)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders

Frontiers in oncology, 2019-03, Vol.9, p.109-109

2019

Volltextzugriff (PDF)

Synthesis of Polycyclic Benzofused Nitrogen Heterocycles via a Tandem Ynamide Benzannulation/Ring-Closing Metathesis Strategy. Application in a Formal Total Synthesis of (+)-FR900482

Journal of organic chemistry, 2011-03, Vol.76 (6), p.1852-1873

2011

Volltextzugriff (PDF)

Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax

Haematologica (Roma), 2024-01, Vol.109 (1), p.186

2024

Volltextzugriff (PDF)

Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy

Haematologica (Roma), 2023-12, Vol.108 (12), p.3433-3437

2023

Volltextzugriff (PDF)

Diffuse Large B-Cell Lymphoma's New Genomics: The Bridge and the Chasm

Journal of clinical oncology, 2020-10, Vol.38 (30), p.3565-3574

2020

Volltextzugriff (PDF)

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility

PloS one, 2018-07, Vol.13 (7), p.e0199708-e0199708

2018

Volltextzugriff (PDF)

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Blood advances, 2020-01, Vol.4 (1), p.122-126

2020

Volltextzugriff (PDF)

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

Nature (London), 1997-03, Vol.386 (6623), p.407-410

1997

Volltextzugriff (PDF)

Current considerations in AYA Hodgkin lymphoma

British journal of haematology, 2019-01, Vol.184 (1), p.72-81

2019

Volltextzugriff (PDF)

Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment

Hematology/oncology clinics of North America, 2019-08, Vol.33 (4), p.575-585

2019

Volltextzugriff (PDF)

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

The lancet oncology, 2021-10, Vol.22 (10), p.1391-1402

2021

Volltextzugriff (PDF)

Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment

Surgical oncology clinics of North America, 2020-01, Vol.29 (1), p.115-125

2020

Volltextzugriff (PDF)

Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)‑9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the Treatment of Acute Severe Pain

Journal of medicinal chemistry, 2013-10, Vol.56 (20), p.8019-8031

2013

Volltextzugriff (PDF)

Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma

Leukemia & lymphoma, 2024-07, p.1-11

2024

Volltextzugriff (PDF)

Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial

The Lancet. Haematology, 2022-05, Vol.9 (5), p.e327-e339

2022

Volltextzugriff (PDF)

Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement

British journal of haematology, 2023-12, Vol.203 (5), p.774-780

2023

Volltextzugriff (PDF)

Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas

Blood, 2019-02, Vol.133 (6), p.566-575

2019

Volltextzugriff (PDF)

The future of antibody therapy in chronic lymphocytic leukemia

Expert opinion on emerging drugs, 2021-07, Vol.26 (3), p.323-336

2021

Volltextzugriff (PDF)

Civic Community in Late Medieval Lincoln: Urban Society and Economy in the Age of the Black Death, 1289–1409, by Alan Kissane

The English historical review, 2018-10, Vol.133 (564), p.1291-1292

Crombie, L

2018

Volltextzugriff (PDF)

Checkpoints: roadblocks or repairs for the CAR-T journey?

Blood advances, 2024-01, Vol.8 (2), p.468-469

2024

Volltextzugriff (PDF)

Ring Expansion-Annulation Strategy for the Synthesis of Substituted Azulenes and Oligoazulenes. 2. Synthesis of Azulenyl Halides, Sulfonates, and Azulenylmetal Compounds and Their Application in Transition-Metal-Mediated Coupling Reactions

Journal of organic chemistry, 2004-12, Vol.69 (25), p.8652-8667

2004

Volltextzugriff (PDF)

1 – 25 von 965

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(550)
Mit Volltextzugriff
(567)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(408)
Life Sciences & Biomedicine
(226)
Humans
(191)
Chemistry
(185)
Physical Sciences
(171)
Chemistry, Organic
(103)
Biological And Medical Sciences
(97)
Female
(95)
Male
(81)
Chemistry, Multidisciplinary
(58)
General & Internal Medicine
(56)
Exact Sciences And Technology
(55)
Medicine, General & Internal
(54)
Organic Chemistry
(54)
Adult
(52)
Medical Sciences
(51)
Middle Aged
(49)
Fundamental And Applied Biological Sciences. Psychology
(48)
Animals
(45)
Aged
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Biased ligands at G-protein-coupled receptors: promise and progress

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders

Synthesis of Polycyclic Benzofused Nitrogen Heterocycles via a Tandem Ynamide Benzannulation/Ring-Closing Metathesis Strategy. Application in a Formal Total Synthesis of (+)-FR900482

Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax

Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy

Diffuse Large B-Cell Lymphoma's New Genomics: The Bridge and the Chasm

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

Current considerations in AYA Hodgkin lymphoma

Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment

Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)‑9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the Treatment of Acute Severe Pain

Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma

Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy

Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement

Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas

The future of antibody therapy in chronic lymphocytic leukemia

Civic Community in Late Medieval Lincoln: Urban Society and Economy in the Age of the Black Death, 1289–1409, by Alan Kissane

Checkpoints: roadblocks or repairs for the CAR-T journey?

Ring Expansion-Annulation Strategy for the Synthesis of Substituted Azulenes and Oligoazulenes. 2. Synthesis of Azulenyl Halides, Sulfonates, and Azulenylmetal Compounds and Their Application in Transition-Metal-Mediated Coupling Reactions

Suchergebnisse filtern